Loading...

WuXi Biologics (Cayman) Inc.

WXXWYPNK
Healthcare
Biotechnology
$8.52
$-0.04(-0.47%)
U.S. Market opens in 2h 4m

WuXi Biologics (Cayman) Inc. (WXXWY) Stock Competitors & Peer Comparison

See (WXXWY) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
WXXWY$8.52-0.47%17.6B25.09$0.34N/A
NONOF$40.32-2.84%178.5B11.13$3.61+4.43%
CSLLY$22.24-3.47%86.1B14.44$1.54+3.16%
UCBJF$273.54-0.74%52.1B29.10$9.40+0.57%
UCBJY$131.58-0.48%50.1B28.00$4.70+0.59%
ARGNF$724.55-7.23%44.8B36.97$19.60N/A
CMXHF$90.00-0.54%43.7B14.59$6.17+3.23%
WXIBF$4.70+0.00%19.4B27.65$0.17N/A
IVBXF$11.08+7.66%19.1B158.25$0.07N/A
GNMSF$255.25-6.10%15.7B16.62$15.36N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

WXXWY vs NONOF Comparison April 2026

WXXWY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WXXWY stands at 17.6B. In comparison, NONOF has a market cap of 178.5B. Regarding current trading prices, WXXWY is priced at $8.52, while NONOF trades at $40.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WXXWY currently has a P/E ratio of 25.09, whereas NONOF's P/E ratio is 11.13. In terms of profitability, WXXWY's ROE is +0.11%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, WXXWY is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for WXXWY.Check NONOF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions